Olivier Govaere

11.0k total citations · 5 hit papers
66 papers, 4.6k citations indexed

About

Olivier Govaere is a scholar working on Epidemiology, Molecular Biology and Hepatology. According to data from OpenAlex, Olivier Govaere has authored 66 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Epidemiology, 22 papers in Molecular Biology and 22 papers in Hepatology. Recurrent topics in Olivier Govaere's work include Liver Disease Diagnosis and Treatment (23 papers), Liver physiology and pathology (14 papers) and Cancer Cells and Metastasis (11 papers). Olivier Govaere is often cited by papers focused on Liver Disease Diagnosis and Treatment (23 papers), Liver physiology and pathology (14 papers) and Cancer Cells and Metastasis (11 papers). Olivier Govaere collaborates with scholars based in Belgium, United Kingdom and Germany. Olivier Govaere's co-authors include Quentin M. Anstee, Helen L. Reeves, Mathias Heikenwälder, Elena Kotsiliti, Tania Roskams, Tom Luedde, Frank Tacke, Christian Trautwein, Baki Topal and Oliver Krenkel and has published in prestigious journals such as Nature Medicine, Gastroenterology and PLoS ONE.

In The Last Decade

Olivier Govaere

65 papers receiving 4.6k citations

Hit Papers

From NASH to HCC: current concepts and futu... 2012 2026 2016 2021 2019 2012 2017 2016 2023 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. From NASH to HCC: current concepts and future challenges
    2019 965 citations Quentin M. Anstee, Helen L. Reeves et al. Nature Reviews Gastroenterology & Hepatology profile →
  2. Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease
    2012 582 citations Olivier Govaere, Tania Roskams et al. profile →
  3. Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis
    2017 421 citations Oliver Krenkel, Tobias Puengel et al. Hepatology profile →
  4. Chemokine (C‐C motif) receptor 2–positive monocytes aggravate the early phase of acetaminophen‐induced acute liver injury
    2016 262 citations Jana C. Mossanen, Oliver Krenkel et al. Hepatology profile →
  5. A proteo-transcriptomic map of non-alcoholic fatty liver disease signatures
    2023 73 citations Olivier Govaere, Leigh Alexander et al. Nature Metabolism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olivier Govaere Belgium 30 1.9k 1.5k 1.4k 997 981 66 4.6k
Yury Popov United States 37 2.2k 1.1× 2.3k 1.5× 1.5k 1.1× 1.1k 1.1× 554 0.6× 71 4.8k
Wei‐Fen Xie China 38 1.0k 0.5× 1.2k 0.8× 2.1k 1.5× 859 0.9× 905 0.9× 116 4.3k
Romil Saxena United States 36 1.8k 0.9× 2.0k 1.3× 1.2k 0.9× 2.3k 2.3× 1.0k 1.1× 129 5.4k
Jens U. Marquardt Germany 40 1.0k 0.5× 1.5k 1.0× 2.1k 1.6× 892 0.9× 1.1k 1.2× 185 4.7k
Hayato Hikita Japan 29 1.4k 0.7× 842 0.5× 1.7k 1.2× 381 0.4× 600 0.6× 133 3.6k
Jesús M. Bañales Spain 41 1.3k 0.7× 1.5k 1.0× 2.4k 1.7× 2.4k 2.4× 1.3k 1.3× 169 6.0k
Jun Itakura Japan 37 1.6k 0.9× 1.8k 1.2× 947 0.7× 745 0.7× 1.1k 1.1× 144 4.0k
Véronique Barbu France 35 963 0.5× 1.1k 0.7× 1.5k 1.1× 1.2k 1.2× 1.1k 1.2× 85 4.1k
Bo Zhai China 37 701 0.4× 889 0.6× 3.1k 2.3× 652 0.7× 1.3k 1.3× 152 5.4k
Éric Letouzé France 30 883 0.5× 1.1k 0.7× 2.6k 1.9× 1.1k 1.1× 895 0.9× 59 5.3k

Countries citing papers authored by Olivier Govaere

Since Specialization
Citations

This map shows the geographic impact of Olivier Govaere's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivier Govaere with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivier Govaere more than expected).

Fields of papers citing papers by Olivier Govaere

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olivier Govaere. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivier Govaere. The network helps show where Olivier Govaere may publish in the future.

Co-authorship network of co-authors of Olivier Govaere

This figure shows the co-authorship network connecting the top 25 collaborators of Olivier Govaere. A scholar is included among the top collaborators of Olivier Govaere based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olivier Govaere. Olivier Govaere is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mol, Hans, Weronika Kowalczyk, Leticia Sansores-García, et al.. (2025). Steatotic liver disease induces YAP/TAZ-driven cell competition that can suppress tumor initiation. Journal of Hepatology. 83(5). 1142–1155. 1 indexed citations
2.
Sabatini, Silvia, Partho Sen, Fabrizia Carli, et al.. (2024). Hepatic glucose production rises with the histological severity of metabolic dysfunction-associated steatohepatitis. Cell Reports Medicine. 5(11). 101820–101820. 6 indexed citations
3.
Verbeek, Jef, Dóra Bihary, Bram Boeckx, et al.. (2024). Comparison of the single-cell and single-nucleus hepatic myeloid landscape within decompensated cirrhosis patients. Frontiers in Immunology. 15. 1346520–1346520. 4 indexed citations
4.
Govaere, Olivier, Leigh Alexander, Simon Cockell, et al.. (2023). A proteo-transcriptomic map of non-alcoholic fatty liver disease signatures. Nature Metabolism. 5(4). 572–578. 73 indexed citations breakdown →
5.
Nicoletti, Paola, Andrew Dellinger, Yi‐Ju Li, et al.. (2022). Identification of Reduced ERAP2 Expression and a Novel HLA Allele as Components of a Risk Score for Susceptibility to Liver Injury Due to Amoxicillin-Clavulanate. Gastroenterology. 164(3). 454–466. 25 indexed citations
6.
McGlinchey, Aidan, Olivier Govaere, Dawei Geng, et al.. (2022). Metabolic signatures across the full spectrum of non-alcoholic fatty liver disease. JHEP Reports. 4(5). 100477–100477. 62 indexed citations
7.
Kodama, Takahiro, Sadatsugu Sakane, Olivier Govaere, et al.. (2021). Transcriptomics Identify Thrombospondin‐2 as a Biomarker for NASH and Advanced Liver Fibrosis. Hepatology. 74(5). 2452–2466. 99 indexed citations
8.
McGlinchey, Aidan, Dawei Geng, Olivier Govaere, et al.. (2020). Metabolomics approaches to identify biomarkers of non-alcoholic fatty liver disease. Journal of Hepatology. 73. S438–S438. 1 indexed citations
9.
Haele, Matthias Van, Iván M. Moya, Ruçhan Karaman, et al.. (2019). YAP and TAZ Heterogeneity in Primary Liver Cancer: An Analysis of Its Prognostic and Diagnostic Role. International Journal of Molecular Sciences. 20(3). 638–638. 44 indexed citations
10.
Anstee, Quentin M., Helen L. Reeves, Elena Kotsiliti, Olivier Govaere, & Mathias Heikenwälder. (2019). From NASH to HCC: current concepts and future challenges. Nature Reviews Gastroenterology & Hepatology. 16(7). 411–428. 965 indexed citations breakdown →
11.
Krenkel, Oliver, Tobias Puengel, Olivier Govaere, et al.. (2017). Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis. Hepatology. 67(4). 1270–1283. 421 indexed citations breakdown →
12.
Govaere, Olivier, Michaela Petz, Jasper Wouters, et al.. (2017). The PDGFRα-laminin B1-keratin 19 cascade drives tumor progression at the invasive front of human hepatocellular carcinoma. Oncogene. 36(47). 6605–6616. 49 indexed citations
13.
Wouters, Jasper, Marguerite Stas, Olivier Govaere, et al.. (2014). A novel hypoxia-associated subset of FN1highMITFlow melanoma cells: identification, characterization, and prognostic value. Modern Pathology. 27(8). 1088–1100. 14 indexed citations
14.
Rodrigues, Robim M., Joery De Kock, Mathieu Vinken, et al.. (2013). Human Skin-Derived Stem Cells as a Novel Cell Source for In Vitro Hepatotoxicity Screening of Pharmaceuticals. Stem Cells and Development. 23(1). 44–55. 47 indexed citations
15.
Hammerich, Linda, Olivier Govaere, Henning W. Zimmermann, et al.. (2013). Chemokine Receptor CCR6-Dependent Accumulation of γδ T Cells in Injured Liver Restricts Hepatic Inflammation and Fibrosis. Hepatology. 59(2). 630–642. 153 indexed citations
16.
broeck, Anke Van den, Hugo Vankelecom, Lies Gremeaux, et al.. (2013). Human Pancreatic Cancer Contains a Side Population Expressing Cancer Stem Cell-Associated and Prognostic Genes. PLoS ONE. 8(9). e73968–e73968. 57 indexed citations
17.
Kock, Joery De, Mehdi Najar, Jennifer Bolleyn, et al.. (2012). Mesoderm-Derived Stem Cells: The Link Between the Transcriptome and Their Differentiation Potential. Stem Cells and Development. 21(18). 3309–3323. 49 indexed citations
18.
broeck, Anke Van den, et al.. (2012). Molecular markers associated with outcome and metastasis in human pancreatic cancer. Journal of Experimental & Clinical Cancer Research. 31(1). 68–68. 62 indexed citations
19.
Govaere, Olivier, Pascal Wolter, Benoit Beuselinck, et al.. (2012). A Possible Role for MicroRNA-141 Down-Regulation in Sunitinib Resistant Metastatic Clear Cell Renal Cell Carcinoma Through Induction of Epithelial-to-Mesenchymal Transition and Hypoxia Resistance. The Journal of Urology. 189(5). 1930–1938. 55 indexed citations
20.
Berkers, J., Olivier Govaere, Pascal Wolter, et al.. (2011). 740 MICRORNA-141 EXPRESSION IN CLEAR CELL RENAL CELL CARCINOMA IS LINKED WITH SUNITINIB RESPONSE. European Urology Supplements. 10(2). 235–236. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yury Popov Breakdown of academic impact, for papers by Wei‐Fen Xie Breakdown of academic impact, for papers by Romil Saxena Breakdown of academic impact, for papers by Jens U. Marquardt Breakdown of academic impact, for papers by Hayato Hikita Breakdown of academic impact, for papers by Jesús M. Bañales Breakdown of academic impact, for papers by Jun Itakura Breakdown of academic impact, for papers by Véronique Barbu Breakdown of academic impact, for papers by Bo Zhai Breakdown of academic impact, for papers by Éric Letouzé
Rankless by CCL
2026